BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 16531870)

  • 1. Silver-coated dressing acticoat caused raised liver enzymes and argyria-like symptoms in burn patient.
    Trop M; Novak M; Rodl S; Hellbom B; Kroell W; Goessler W
    J Trauma; 2006 Mar; 60(3):648-52. PubMed ID: 16531870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Randomized Controlled Study of Silver-Based Burns Dressing in a Pediatric Emergency Department.
    Brown M; Dalziel SR; Herd E; Johnson K; Wong She R; Shepherd M
    J Burn Care Res; 2016; 37(4):e340-7. PubMed ID: 26171678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of efficacy of 1% silver sulfadiazine and Acticoat for treatment of partial-thickness burn wounds.
    Muangman P; Chuntrasakul C; Silthram S; Suvanchote S; Benjathanung R; Kittidacha S; Rueksomtawin S
    J Med Assoc Thai; 2006 Jul; 89(7):953-8. PubMed ID: 16881426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silver-coated dressing acticoat caused raised liver enzymes and argyria-like symptoms in burn patient.
    Trop M
    J Trauma; 2006 Oct; 61(4):1024. PubMed ID: 17033588
    [No Abstract]   [Full Text] [Related]  

  • 5. A matched-pair, randomized study evaluating the efficacy and safety of Acticoat silver-coated dressing for the treatment of burn wounds.
    Tredget EE; Shankowsky HA; Groeneveld A; Burrell R
    J Burn Care Rehabil; 1998; 19(6):531-7. PubMed ID: 9848045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A silver-coated antimicrobial barrier dressing used postoperatively on meshed autografts: a dressing comparison study.
    Silver GM; Robertson SW; Halerz MM; Conrad P; Supple KG; Gamelli RL
    J Burn Care Res; 2007; 28(5):715-9. PubMed ID: 17667837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Acticoat dressings in burns: what is the evidence?
    Khundkar R; Malic C; Burge T
    Burns; 2010 Sep; 36(6):751-8. PubMed ID: 20346592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acticoat dressings and major burns: systemic silver absorption.
    Moiemen NS; Shale E; Drysdale KJ; Smith G; Wilson YT; Papini R
    Burns; 2011 Feb; 37(1):27-35. PubMed ID: 20961690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefit of hydrocolloid SSD dressing in the outpatient management of partial thickness burns.
    Muangman P; Muangman S; Opasanon S; Keorochana K; Chuntrasakul C
    J Med Assoc Thai; 2009 Oct; 92(10):1300-5. PubMed ID: 19845237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of cytotoxicity and antimicrobial activity of Acticoat Burn Dressing for management of microbial contamination in cultured skin substitutes grafted to athymic mice.
    Supp AP; Neely AN; Supp DM; Warden GD; Boyce ST
    J Burn Care Rehabil; 2005; 26(3):238-46. PubMed ID: 15879745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A silver coated dressing reduces the incidence of early burn wound cellulitis and associated costs of inpatient treatment: comparative patient care audits.
    Fong J; Wood F; Fowler B
    Burns; 2005 Aug; 31(5):562-7. PubMed ID: 15993301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of silver-coated dressing (Acticoat), chlorhexidine acetate 0.5% (Bactigrass), and silver sulfadiazine 1% (Silverdin) for topical antibacterial effect in Pseudomonas aeruginosa-contaminated, full-skin thickness burn wounds in rats.
    Ulkür E; Oncül O; Karagöz H; Celiköz B; Cavuşlu S
    J Burn Care Rehabil; 2005; 26(5):430-3. PubMed ID: 16151289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multi-center clinical study of acticoat (nanocrystalline silver dressing) for the management of residual burn wounds].
    Li XL; Huang YS; Peng YZ; Liao ZJ; Zhang GA; Liu Q; Tang J; Liu XS; Luo QZ
    Zhonghua Shao Shang Za Zhi; 2006 Feb; 22(1):15-8. PubMed ID: 16680954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healing at home: Comparing cohorts of children with medium-sized burns treated as outpatients with in-hospital applied Acticoat to those children treated as inpatients with silver sulfadiazine.
    Peters DA; Verchere C
    J Burn Care Res; 2006; 27(2):198-201. PubMed ID: 16566565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silver-coated dressing Acticoat.
    Parkes A
    J Trauma; 2006 Jul; 61(1):239-40. PubMed ID: 16832285
    [No Abstract]   [Full Text] [Related]  

  • 16. A prospective, randomized trial of Acticoat versus silver sulfadiazine in the treatment of partial-thickness burns: which method is less painful?
    Varas RP; O'Keeffe T; Namias N; Pizano LR; Quintana OD; Herrero Tellachea M; Rashid Q; Ward CG
    J Burn Care Rehabil; 2005; 26(4):344-7. PubMed ID: 16006842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An in vitro study of the anti-microbial efficacy of a 1% silver sulphadiazine and 0.2% chlorhexidine digluconate cream, 1% silver sulphadiazine cream and a silver coated dressing.
    Fraser JF; Bodman J; Sturgess R; Faoagali J; Kimble RM
    Burns; 2004 Feb; 30(1):35-41. PubMed ID: 14693084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized comparative trial between Acticoat and SD-Ag in the treatment of residual burn wounds, including safety analysis.
    Huang Y; Li X; Liao Z; Zhang G; Liu Q; Tang J; Peng Y; Liu X; Luo Q
    Burns; 2007 Mar; 33(2):161-6. PubMed ID: 17175106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of paediatric burns with a nanocrystalline silver dressing compared with standard wound care in a burns unit: a cost analysis.
    Cox SG; Cullingworth L; Rode H
    S Afr Med J; 2011 Sep; 101(10):728-31. PubMed ID: 22272852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Case of Argyria and Acute Leukopenia Associated with the Use of an Antimicrobial Soft Silicone Foam Dressing.
    McCague A; Joe VC
    J Burn Care Res; 2016; 37(5):e493-6. PubMed ID: 26284628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.